BR9811865A - Isolamento de um novo gene de fator de senescência, p23 - Google Patents

Isolamento de um novo gene de fator de senescência, p23

Info

Publication number
BR9811865A
BR9811865A BR9811865-0A BR9811865A BR9811865A BR 9811865 A BR9811865 A BR 9811865A BR 9811865 A BR9811865 A BR 9811865A BR 9811865 A BR9811865 A BR 9811865A
Authority
BR
Brazil
Prior art keywords
senescence
isolation
new
factor gene
polypeptide
Prior art date
Application number
BR9811865-0A
Other languages
English (en)
Inventor
Karen Swisshelm
Suzanne Hosier
Manfred Kubbies
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of BR9811865A publication Critical patent/BR9811865A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Patente da Invenção: <B>"ISOLAMENTO DE UM NOVO GENE DE FATOR DE SENESCêNCIA, p23"<D>. São fornecidos uma molécula de ácido nucléico relacionada à senescência isolada que codifica um polipeptídeo de 23 quilodáltons (p23), métodos para expressar o polipeptídeo de 23 quilodáltons em células cultivadas, polipeptídeos p23 recombinantes vetores de expressão e células hospedeiras que expressam p23 e anticorpos contra p23. Também são fornecidos métodos para usar p23 para modular senescência e para determinar a expressão de p23 em amostras biológicas.
BR9811865-0A 1997-08-08 1998-08-05 Isolamento de um novo gene de fator de senescência, p23 BR9811865A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90887397A 1997-08-08 1997-08-08
PCT/US1998/016343 WO1999007893A1 (en) 1997-08-08 1998-08-05 ISOLATION OF A NOVEL SENESCENCE-FACTOR GENE, p23

Publications (1)

Publication Number Publication Date
BR9811865A true BR9811865A (pt) 2000-08-15

Family

ID=25426353

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9811865-0A BR9811865A (pt) 1997-08-08 1998-08-05 Isolamento de um novo gene de fator de senescência, p23

Country Status (9)

Country Link
EP (1) EP1012333A4 (pt)
JP (1) JP2001512698A (pt)
KR (1) KR20010022741A (pt)
CN (1) CN1270637A (pt)
AU (1) AU8693598A (pt)
BR (1) BR9811865A (pt)
CA (1) CA2296598A1 (pt)
TR (1) TR200000331T2 (pt)
WO (1) WO1999007893A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2344400T3 (es) * 2000-01-21 2010-08-26 Polymun Scientific Immunbiologische Forschung Gmbh Marcador tumoral y de senescencia.
AU750296B2 (en) * 2000-06-23 2002-07-11 F. Hoffmann-La Roche Ag Antibodies against SEMP1, methods for their production and uses thereof
EP1325020A4 (en) * 2000-09-20 2004-12-15 Human Genome Sciences Inc 21 HUMANE SECONDED PROTEINS
US7125663B2 (en) 2001-06-13 2006-10-24 Millenium Pharmaceuticals, Inc. Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
US20110105961A1 (en) * 2008-05-23 2011-05-05 Gruber Lewis S Methods, compositions and apparatuses for facilitating regeneration
ES2725852T3 (es) 2010-09-27 2019-09-27 Siwa Corp Eliminación selectiva de células modificadas por AGE para el tratamiento de la aterosclerosis
US8721571B2 (en) 2010-11-22 2014-05-13 Siwa Corporation Selective removal of cells having accumulated agents
ES2908203T3 (es) 2014-09-19 2022-04-28 Siwa Corp Anticuerpos anti-age para el tratamiento de inflamación y trastornos autoinmunes
US10358502B2 (en) 2014-12-18 2019-07-23 Siwa Corporation Product and method for treating sarcopenia
US9993535B2 (en) 2014-12-18 2018-06-12 Siwa Corporation Method and composition for treating sarcopenia
RU2728964C2 (ru) 2016-02-19 2020-08-03 Сива Корпорейшн Способ и композиция для лечения рака, уничтожения метастатических раковых клеток и профилактики метастазов рака, используя антитела к конечным продуктам повышенного гликирования ( AGE)
CN109311975A (zh) 2016-04-15 2019-02-05 Siwa有限公司 用于治疗神经退行性紊乱的抗age抗体
US11213585B2 (en) 2016-06-23 2022-01-04 Siwa Corporation Vaccines for use in treating various diseases and disorders
US10858449B1 (en) 2017-01-06 2020-12-08 Siwa Corporation Methods and compositions for treating osteoarthritis
US10925937B1 (en) 2017-01-06 2021-02-23 Siwa Corporation Vaccines for use in treating juvenile disorders associated with inflammation
US10995151B1 (en) 2017-01-06 2021-05-04 Siwa Corporation Methods and compositions for treating disease-related cachexia
US10961321B1 (en) 2017-01-06 2021-03-30 Siwa Corporation Methods and compositions for treating pain associated with inflammation
CA3059803A1 (en) 2017-04-13 2018-10-18 Siwa Corporation Humanized monoclonal advanced glycation end-product antibody
US11518801B1 (en) 2017-12-22 2022-12-06 Siwa Corporation Methods and compositions for treating diabetes and diabetic complications

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744300A (en) * 1993-03-24 1998-04-28 Geron Corporation Methods and reagents for the identification and regulation of senescence-related genes
US5580726A (en) * 1994-04-29 1996-12-03 Geron Corporation Method and Kit for enhanced differential display
US6416974B1 (en) * 1997-08-06 2002-07-09 Millennium Pharmaceuticals, Inc. Tango 71 nucleic acids
ES2312205T3 (es) * 1998-03-10 2009-02-16 Genentech, Inc. Nuevo polipeptido y acidos nucleicos que lo codifican.
WO2000000609A2 (en) * 1998-06-29 2000-01-06 Incyte Pharmaceuticals, Inc. Molecules associated with apoptosis

Also Published As

Publication number Publication date
EP1012333A1 (en) 2000-06-28
KR20010022741A (ko) 2001-03-26
JP2001512698A (ja) 2001-08-28
AU8693598A (en) 1999-03-01
WO1999007893A1 (en) 1999-02-18
EP1012333A4 (en) 2003-01-02
CN1270637A (zh) 2000-10-18
TR200000331T2 (tr) 2000-05-22
CA2296598A1 (en) 1999-02-18

Similar Documents

Publication Publication Date Title
BR9811865A (pt) Isolamento de um novo gene de fator de senescência, p23
ES2177475T1 (es) Genes de corynebacterium glutamicum que codifican proteinas de una ruta metabolica.
BR9914643A (pt) Vetores adeno-associados para expressão dofator viii por células alvo
MX428A (es) Region regulatoria para expresion de gen heterologa en levadura.
DE69635864D1 (de) Rekombinante rna-replikase von hepatitis-c-virus
BR0214350A (pt) Sequências de ácido nucleico e aminoácido de adenovìrus de sìmio, vetores contendo as mesmas e métodos de uso
WO1996039429A3 (en) Serum protein produced exclusively in adipocytes
NZ323834A (en) Chimeric adenovirus coat protein vectors and methods for gene transfer to cells
NO20020861L (no) Nye B7-4-molekyler og anvendelser derav
AR056723A2 (es) Polipeptido purificado metodo para producirlo , metodo para identificarlo y/ o aislarlo composicion farmaceutica que lo comprende, secuencia de acidos nucleicos aislada que codifica dicho polipeptido, vector que contiene a dicha secuencia celula huesped transfectada por dicho vector, sonda nucleotid
MY120693A (en) Human bikunin
EP1798239A3 (en) G-protein coupled receptors and uses therefor
BR9908018A (pt) Adenovìrus modificado contendo uma proteìna de substituição de fibra
EP0804609A4 (en) NEW GENES OF RESPONSE p53
ES2259190T3 (es) Composiciones y metodos para la biosintesis de taxol.
KR960010863A (ko) 재조합 머사시딘 및 이의 제조방법
AU5559499A (en) Identification of the gene causing the mouse scurfy phenotype and its human ortholog
DE69504808D1 (de) Corticotropin freisetzende rezeptoren des faktor 2
BR9811850A (pt) Expressão recombinante de peptìdeo c de insulina
BR0316510A (pt) Vetor de expressão, processo para a preparação de produtos gênicos heterólogos e processo de seleção para células recombinantes de alta produção
EP1412374A4 (en) NEW PGC-1 ISOFORMS AND THEIR USES
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO1999020761A3 (en) Compositions and methods for identifying and testing therapeutics against hsv infection
AU2001249649A1 (en) 16836, a novel human phospholipase c family member and uses thereof
BR9910414A (pt) Proteìna isolada, ácido nucleico isolado, vetor para a expressão de uma 13-hidroperóxido liase de psidium guajava, célula contendo um ácido nucleico exógeno, e, processos para clivar um 13-hidroperóxido de ácido linoleico ou de um alfa-linolênico em um aldeìdo c6 e um ácido oxocarboxìlico c12, para preparar n-hexanal, 3- (z)-hexen-1-al, 2- (e)-hexen-1-al ou seus álcoois correspondentes, e para expressar uma proteìna recombinante

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired